Cite

1. Kostova I. Platinum complexes as anticancer agents. Recent Pat Anticancer Drug Discov. 2006; 1(1):1-22.10.2174/15748920677524645818221023Search in Google Scholar

2. Alderden RA, Hall MD, Hambley TW. The Discovery and Development of Cisplatin. J Chem Educ. 2006; 83(5): 728-33.10.1021/ed083p728Open DOISearch in Google Scholar

3. Florea АМ, Busselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers. 2011; 3(1): 1351-71.10.3390/cancers3011351375641724212665Search in Google Scholar

4. Mishra AK, Mishra SB, Manav N, Saluja D, Chandra R, Kaushik NK. Synthesis, characterization, antibacterial and cytotoxic study of platinum(IV) complexes. Bioorg Med Chem. 2006; 14(18): 6333-40.10.1016/j.bmc.2006.05.04716765599Open DOISearch in Google Scholar

5. Mishra AK, Kaushik NK. Synthesis, characterization, cytotoxicity, antibacterial and antifungal evaluation of some new platinum(IV) and palladium(II) complexes of thiodiamines. Eur J Med Chem. 2007; 42(10): 1239-46.10.1016/j.ejmech.2007.03.01717498848Search in Google Scholar

6. Wong E, Giandomenico CM. Current status of platinum- based antitumor drugs. Chem Rev. 1999; 99(9): 2451-66.10.1021/cr980420v11749486Search in Google Scholar

7. Manav N, Mishra AK, Kaushik NK. In vitro antitumour and antibacterial studies of some Pt(IV) dithiocarbamate complexes. Spectrochim Acta A Mol Biomol Spectrosc. 2006; 65(1): 32-5.10.1016/j.saa.2005.09.02316522376Search in Google Scholar

8. Mishra AK, Mishra SB, Manav N, Kumar R, Chandra R, Saluja D, Kaushik NK. Platinum(IV) thiohydrazide, thiodiamine and thiohydrazone complexes: A spectral, antibacterial and cytotoxic study. Spectrochim Acta A Mol Biomol Spectrosc. 2007; 66(4): 1042-7.10.1016/j.saa.2006.04.03816920010Search in Google Scholar

9. Hall MD, Mellor HR, Callaghan R, Hambley TW. Basis for design and development of platinum(IV) anticancer complexes. J Med Chem. 2007; 50(15): 3403-11.10.1021/jm070280u17602547Open DOISearch in Google Scholar

10. Shader D, Ahluwalia GS, Grosso D. Method of reducing hair growth employing sulfhydryl active compounds. Unated States Patent. 1995.Search in Google Scholar

11. Wiener JH, Kloog Y, Wacheck V, Burkhard J. Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo. J Invest Dermatol. 2003; 120 (1): 1-7.10.1046/j.1523-1747.2003.12009.x12535206Search in Google Scholar

12. Smalley KSM, Eisen TG. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. Int J Cancer. 2002; 98: 514-22.10.1002/ijc.10213Open DOISearch in Google Scholar

13. Asadi S, Zhang B, Weng Z, Angelidou A, Kempuraj D, Alysandratos KD, Theoharides TC. Luteolin and thiosalicylate inhibit HgCl2 and thimerosal-induced VEGF release from human mast cells. Int J Immunopathol Pharmacol. 2010; 23(4): 1015-20.10.1177/039463201002300406Search in Google Scholar

14. Smith DJ, Yap GP, Kelley JA, Schneider JP. Enhanced stereoselectivity of a Cu(II) complex chiral auxiliary in the synthesis of Fmoc-L-γ-carboxyglutamic acid. J Org Chem. 2011; 76(6):1513-20.10.1021/jo101940kSearch in Google Scholar

15. Radić GP, Glođović VV, Radojević ID, Stefanović OD, Čomić LjR, Ratković ZR, Valkonen A, Rissanen K, Trifunović SR. Synthesis, characterization and antimicrobial activity of palladium(II) complexes with some alkyl derivates of thiosalicylic acids. Crystal structure of bis(S-benzyl-thiosalicylate)-palladium(II) complex, [Pd(S-bz-thiosal)2]. Polyhedron. 2012; 31: 69-76.10.1016/j.poly.2011.08.042Search in Google Scholar

16. Smith DJ, Yap GP, Kelley JA, Schneider JP. Enhanced stereoselectivity of a Cu(II) complex chiral auxiliary in the synthesis of Fmoc-L-γ-carboxyglutamic acid. J Org Chem. 2011; 76(6): 1513-20.10.1021/jo101940kSearch in Google Scholar

17. Agilent, CrysAlis PRO, Agilent Technologies, Yarnton, Oxfordshire, England (2010) Search in Google Scholar

18. (a) Altomare A, Burla MC, Cavalli M, Cascarano G, Giacovazzo C, Gagliardi A, Moliterni AG. Polidori G, Spagna R, Sir97: A New Program For Solving and Refining Crystal Structures, Istituto di Ricerca per lo Sviluppo di Metodologie Cristallografiche CNR, Bari (1997); (b) Altomare A, Burla MC, Cavalli M, Cascarano G, Giacovazzo C, Gagliardi A, Moliterni GG, Polidori G, Spagna R, SIR97: a new tool for crystal structure determination and refinement. J Appl Cryst. 1999; 32: 115-119.Search in Google Scholar

19. Sheldrick GM. SHELXS-97 and SHELXL-97. Programs for solution and refinement of crystal structures from diffraction data, University of Gottingen, Germany, 1997, Acta Crystallogr. 2008; A64: 112-22.Search in Google Scholar

20. Farrugia LJ, WinGX suite for small-molecule singlecrystal crystallography, University of Glasgow, Scotland, 1998; J Appl Cryst. 1999; 32: 837-8.10.1107/S0021889899006020Search in Google Scholar

21. Farrugia LJ. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI), University of Glasgow, Scotland, 1997; J.Appl Cryst 1997; 30: 565.10.1107/S0021889897003117Search in Google Scholar

22. Spek AL. Structure validation in chemical crystallography. Acta Crystallogr. 2009; D65: 148-55.10.1107/S090744490804362XSearch in Google Scholar

23. Schoenberg LN, Cooke DW, Liu CF. Nuclear magnetic resonance determination of the absolute configuration of complexes of cobalt(III) with asymmetric tetradentate ligands. Inorg Chem. 1968; 7: 2386-93.10.1021/ic50069a040Open DOISearch in Google Scholar

24. Swaminathan K, Busch DH. The synthesis and infrared absorption spectra of complexes of cobalt with pentadentate propylenediaminetetraacetic acid. J Inorg Nucl Chem. 1961; 20(1): 159-63.10.1016/0022-1902(61)80475-2Open DOISearch in Google Scholar

25. Nakamoto К. Infrared spectra of the inorganic and coordination compounds. New York: Willey; 1963.Search in Google Scholar

26. Silverstein RM, Bassler CG, Morril TC. Spectrometric identification of organic compounds, 3rd ed. Wiley International Edition, 1974. p.113.Search in Google Scholar

27. Nakamoto K. Infrared Spectra of Inorganic and Coordination Compounds, Wiley, New York, 1963. p. 206.Search in Google Scholar

28. Sim GA, Monteath Robertson J, Goodwin TH. The crystal and molecule structure of benzoic acid, Acta Cryst. 1955; 8: 157-64.10.1107/S0365110X55000601Search in Google Scholar

29. Jones RE, Templeton DH. The crystal structure of acetic acid. Acta Cryst. 1958; 11(7): 484-8.10.1107/S0365110X58001341Search in Google Scholar

30. Wright WB, King GSD. The crystal structure of nicotinic acid. Acta Cryst. 1953; 6: 305-17.10.1107/S0365110X53000867Search in Google Scholar

31. Van Schalkwyk TGD. The crystal structure of phthalic acid. Acta Cryst. 1954; 7(11): 775.10.1107/S0365110X54002344Search in Google Scholar

32. Cohran W. The crystal and molecular structure of salicylic acid. Acta Cryst. 1953; 6: 260-268.10.1107/S0365110X53000752Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, other